derinet® Switzerland
Product names from:
VontobelSVSP
Back

8.15% (5.43% p.a.) Multi Defender VONTI on Clariant, Novartis, Roche, Vifor Pharma

  • Valor 48042266
  • ISIN CH0480422663
  • Symbol RMALUV
sustainable
Bid (indicative)%
Size
Ask (indicative)%
Size
CurrencyCHF
Price on
Sell
Buy
  • sustainable
Novartis AGCHF 
Roche Holding AGCHF 
Clariant AGCHF 
Vifor Pharma AGCHF 
Please note that this is an indication.

Documents

Key data
Riskbuffer29.90%
Interest
Coupon (Coupon p.a.)8.15% (5.43%)
Accrued interest6.40%
Premium component8.1500%
Interest share0.00%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing12/07/2019
First Trading Day18/07/2019
Payment date19/07/2019
Final fixing12/01/2021
Redemption19/01/2021
Barrier reachedno

Current price information

Intraday1 week1 monthyear to date1 yearSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
CHF 18.35CHF 16.36CHF 10.63
CHF 81.67CHF 87.14CHF 56.64
CHF 340.35CHF 262.70CHF 170.76
CHF 131.40CHF 141.70CHF 92.11

No chart available

Key data
Riskbuffer29.90%
Interest
Coupon (Coupon p.a.)8.15% (5.43%)
Accrued interest6.40%
Premium component8.1500%
Interest share0.00%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing12/07/2019
First Trading Day18/07/2019
Payment date19/07/2019
Final fixing12/01/2021
Redemption19/01/2021
Barrier reachedno
Figures
Product typeMulti Defender VONTI
SSPA categorisationBarriere Reverse Convertible
Nominal valueCHF 1,000.00
Reference currencyCHF
QuantoNo
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier65.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program